In a prospective study of nearly 3,000 trauma survivors, PTSD symptoms predicted increased tobacco, alcohol, and cannabis use — with prior trauma history and sociodemographic factors determining who was most at risk.
Read this if you've experienced trauma and want to understand the relationship between PTSD and substance use — or if you're a clinician looking for evidence to guide early intervention.
What the researchers found
The link between PTSD and substance use is well-established, but most studies look backward — asking people who already have both conditions about their history. This study did something much harder: it followed nearly 3,000 people forward in time after they showed up at emergency departments following traumatic events, tracking both PTSD symptoms and substance use at six time points.
PTSD symptoms at one time point predicted increased substance use at the next, confirming a prospective relationship for tobacco, alcohol, and cannabis. This temporal ordering — PTSD symptoms first, then increased substance use — supports the self-medication hypothesis: people develop traumatic stress symptoms and then increase their substance use to cope.
But the most valuable contribution is the risk stratification. Using a machine learning approach (causal forests) with 128 potential variables, the researchers identified which factors most strongly modified the PTSD-to-substance-use pathway. Prior trauma history and sociodemographic characteristics emerged as the most important effect modifiers, meaning the PTSD-substance use link was much stronger in some people than others.
The study also separated incident substance use (starting a new substance) from prevalent use (increasing existing use), finding different patterns for each. This distinction matters for prevention: keeping trauma survivors from starting new substances may require different strategies than preventing escalation in existing users.
Why it matters
Knowing that PTSD leads to increased substance use is important, but knowing who is most vulnerable is actionable. If clinicians can identify trauma survivors at highest risk for developing substance use problems — based on their prior trauma history and sociodemographic profile — they can target early interventions to the people who need them most, rather than treating all trauma survivors the same.
The numbers in context
2,943 participants. 37.3% (n=1,099) had likely PTSD at baseline. Six assessment time points. PTSD was associated with increased tobacco frequency (IRR: 1.003), with stronger associations for certain subgroups. 128 potential effect modifiers tested via causal forests. Prior trauma and sociodemographic factors were the strongest modifiers of the PTSD-substance use relationship.
How the study worked
Prospective cohort from the AURORA study: 2,943 adults presenting at emergency departments after traumatic events. Self-reported PTSD symptoms and substance use (tobacco, alcohol, cannabis) at six time points. Poisson generalized estimating equations assessed lagged associations between PTSD and future substance use. Causal forests identified the most important effect modifiers among 128 potential variables.
Who was studied
N=2,943 adults presenting at emergency departments, no specific age or sex distribution reported.
What this study cannot tell us
Self-reported substance use may be underreported. The AURORA cohort recruited from emergency departments, which may not represent all trauma survivors. While the prospective design supports temporal ordering (PTSD → substance use), it still can't definitively prove causation — a third variable could drive both. The causal forest identifies important modifiers but can't establish why they modify the relationship. Cannabis use was not the primary focus and wasn't analyzed separately in detail.
How to read the evidence
Prospective cohort study with sophisticated statistical methods (causal forests, lagged analysis). The temporal ordering strengthens causal inference compared to cross-sectional studies, though residual confounding remains possible.
When this study was published
Published in 2024. The AURORA study is ongoing and may produce additional longitudinal findings.
The bigger picture
This prospective data provides the temporal evidence that RTHC-00113 (chronic pain rewiring the reward system) described at the neurobiological level. PTSD creates emotional distress → distress drives self-medication → substances provide temporary relief → use escalates. The causal forest approach to risk stratification is methodologically sophisticated and connects to the meta-analytic PTSD treatment findings in RTHC-00117.
Replication
Not stated in abstract.
Funding
Not reported in abstract.
Conflicts of interest
Not reported in abstract.
Questions still open
- Would early PTSD treatment in the emergency department reduce subsequent substance use? Can the risk stratification model be deployed clinically to flag high-risk trauma survivors? Do the effect modifiers identified here (prior trauma, demographics) work through the dopaminergic mechanisms described in RTHC-00113? Would cannabis-specific analyses reveal different risk patterns than the combined substance use analysis?
Read the original research
Post-traumatic stress and future substance use outcomes: leveraging antecedent factors to stratify risk.
Frontiers in psychiatry, 15, 1249382
Frontiers in Psychiatry is a peer-reviewed journal focusing on psychiatric research and clinical practice.
Citation
Garrison-Desany, Henri M; Meyers, Jacquelyn L; Linnstaedt, Sarah D; House, Stacey L; Beaudoin, Francesca L; An, Xinming; Zeng, Donglin; Neylan, Thomas C; Clifford, Gari D; Jovanovic, Tanja; Germine, Laura T; Bollen, Kenneth A; Rauch, Scott L; Haran, John P; Storrow, Alan B; Lewandowski, Christopher; Musey, Paul I; Hendry, Phyllis L; Sheikh, Sophia; Jones, Christopher W; Punches, Brittany E; Swor, Robert A; Gentile, Nina T; Hudak, Lauren A; Pascual, Jose L; Seamon, Mark J; Harris, Erica; Pearson, Claire; Peak, David A; Domeier, Robert M; Rathlev, Niels K; O'Neil, Brian J; Sergot, Paulina; Sanchez, Leon D; Bruce, Steven E; Joormann, Jutta; Harte, Steven E; McLean, Samuel A; Koenen, Karestan C; Denckla, Christy A. (2024). Post-traumatic stress and future substance use outcomes: leveraging antecedent factors to stratify risk.. Frontiers in psychiatry, 15, 1249382. https://doi.org/10.3389/fpsyt.2024.1249382
Explore the wider topic
- Weed Withdrawal Anxiety in Public: When Leaving the House Feels Impossible
- The DARE Response to Anxiety for Cannabis Withdrawal
- The Cannabis Withdrawal Anxiety Toolkit: Quick Techniques That Work
- Why Anxiety Gets Worse Before It Gets Better After Quitting Weed
- Breathing Exercises for Weed Withdrawal Anxiety
- Cannabis-Induced Anxiety: When Weed Stops Being Fun
- Does Weed Help or Hurt Anxiety? What Research Actually Shows
- Grounding Techniques for Cannabis Withdrawal: A Practical Toolkit
- Quitting Weed with Health Anxiety: Why Every Symptom Feels Like a Crisis
- How to Manage Anxiety Without Weed: 15 Evidence-Based Alternatives
- Quitting Weed with Anxiety Disorder: A Careful Approach
- Quitting Weed When You're on Anxiety Medication: What to Know
- Self-Medicating Anxiety with Weed: Why It Works Until It Doesn't
- Do I Need Therapy to Quit Weed? When Professional Help Makes Sense
- Weed and Anxiety: The Paradox That Traps People
- The Biphasic Effect: Low-Dose Calms, High-Dose Panics
- Weed and Generalized Anxiety Disorder (GAD): Why It Backfires
- Weed and Panic Attacks: The Connection Nobody Talks About
- Weed and Paranoia: When Cannabis Turns Your Mind Against You
- Weed and Social Anxiety: Why It Feels Like the Only Thing That Helps
- Why Weed Stopped Working for Your Anxiety
- Weed Withdrawal Anxiety: Understanding the Panic and How to Cope
- Weed Withdrawal Panic Attacks at Night: Why They Happen and How to Get Through Them
- Going Back to Work During Weed Withdrawal: Managing Anxiety and Staying Functional
- Withdrawal Anxiety vs Pre-Existing Anxiety: How to Tell the Difference